Researchers at Scripps Research Institute found that injecting cytokine-antibody complexes stimulates a massive selective increase in T cell response. The study suggests these complexes could be clinically useful for selectively boosting or inhibiting immune responses in vivo, potentially treating autoimmune disease and cancer.
Researchers at Scripps Research Institute have created a detailed snapshot of a cocaine antibody's dynamics, revealing its potential as a therapeutic agent for treating addiction. The study's findings provide insight into the molecular basis of catalysis and suggest possible mutations to enhance the antibody's efficacy.
Researchers successfully synthesized a novel vancomycin analogue with enhanced binding ability, showing promise in treating vancomycin-resistant infections. The new compound could potentially lead to the development of more effective antibiotics against these resistant strains.
Researchers found that overexpression of Nod1 inhibits estrogen-dependent tumor growth in human breast cancer cells, leading to reduced tumor formation and growth. The study suggests a new mechanism for controlling estrogen-sensitive breast cancers and opens the door for future development of novel therapeutics.
The mammalian transcriptome has been completely mapped, showing a massive abundance of noncoding RNAs and antisense genes. This discovery has significant implications for our understanding of genetics, gene regulation, and cellular functions.
Researchers at Scripps Research and GNF develop a strategy to identify functions of noncoding RNAs, which are abundant in human cells. The team screened a library of noncoding RNAs and identified eight that appeared to have functional roles, including one that regulates nuclear factor of activated T-cells (NFAT) signaling.
Scientists aim to develop technology enabling sequence of a single piece of DNA, reducing cost from $10M to $1,000 or less. The goal is to cut the cost of whole-genome sequencing to enable individual genome sequencing in routine medical care.
Researchers describe the interaction between T-cell receptors and coreceptors during an immune response. They found that T-cell receptors and CD8 coreceptors are brought together during antigen sensing, increasing their interaction with endogenous non-stimulatory peptides.
The Joint Center for Structural Genomics will determine a large number of high-resolution structures of biological molecules using new methods and technologies. The researchers aim to tackle challenging structures such as large protein assemblies and proteins essential for all organisms.
Researchers have identified a molecular mechanism controlling lung dryness and fluid entry, potentially leading to better prognosis for those with acute respiratory distress syndrome. The discovery focuses on the SIP3 receptor, which, when activated, causes pulmonary edema, offering new avenues for treatment.
The structure reveals new details about TLR3's binding site for double-stranded RNA and its potential role in detecting viral invaders. This breakthrough may help scientists understand the function of TLR proteins and identify potential therapeutic targets for diseases.
Researchers found that CD22 targets its own molecule to regulate B cell activation. This discovery is crucial for understanding the complete picture of how CD22 and B cells work, which can lead to new ways of addressing immunologic disorders involving B cell activation.
The NIH is funding a high-throughput screening center network at Scripps Research Institute and Scripps Florida to identify proof-of-concept molecules for studying human health and developing new treatments. The three-year grant aims to accelerate the application of chemical biology to understand physiology and pathophysiology.
Raw garlic activates TRPV1 and TRPA1 ion channel proteins in pain-sensing neurons, detecting temperature and pain. The loss of allicin when garlic is cooked accounts for the change in pungency.
Researchers at Scripps Institute find a protein called LexA promotes mutations in bacteria, enabling them to evolve resistance to antibiotics. By inhibiting this protein, the bacteria's ability to evolve can be halted, potentially prolonging the potency of existing antibiotics.
Researchers have discovered the structure of a membrane transporter protein used by bacteria and human cancer cells to evade drugs. This finding could lead to improved cancer therapy and more effective treatments for antibiotic-resistant infections. The protein, MsbA, plays a crucial role in bacterial cell growth and is now being studi...
Scientists discovered that mice lacking LPA receptors experience fertility problems, with embryos failing to implant in the womb. This finding may lead to new insights into female infertility and potential therapeutic interventions for human fertility issues.
Scripps Research scientists identified that certain tissues are more susceptible to amyloid plaques due to their ability to efficiently release misfolded protein. The study found that cells secreting proteins into these tissues secrete the bad proteins most efficiently, making them a key factor in tissue selectivity.
Scientists have discovered that microRNA works in conjunction with multiple proteins to target messenger RNA, regulating genetic expression. This discovery sheds light on the stability and degradation of mRNA, a crucial process in controlling gene expression and preventing diseases like cancer and septic shock.
Researchers at Scripps Research Institute have discovered TRPV3, a protein that detects warm temperatures through skin cells, not sensory neurons. The receptor is activated by both thermal heat and the compound camphor, leading to new insights into pain sensation and potential drug targets.
Researchers at The Scripps Research Institute have identified an antibody called 4E10 that can neutralize nearly 100 different HIV strains. This breakthrough could lead to the development of a more effective HIV vaccine by targeting this specific epitope.
Researchers at Scripps Research Institute use a class of compounds known as Src kinase inhibitors to stabilize blood vessels and block tumor cell metastasis. By increasing the protective barrier strength of host blood vessels, the approach prevents cancer cells from exiting the bloodstream, making them vulnerable to immune system attack.
Researchers have found that carbonyl sulfide forms peptide bonds spontaneously, addressing a long-standing question in the origin of life. The discovery suggests that this chemical component may have played a significant role in the emergence of life on Earth.
The grant aims to develop rapid, efficient methods for producing membrane protein samples for structure determination and physiological function investigation. Membrane proteins are a major target for many drugs on the market, and this research has significant medical potential.
A team of scientists at Scripps Research Institute has discovered a new genetic component of the mammalian clock, known as Rora. This discovery holds promise for understanding circadian rhythms and their role in health and disease, including conditions like jet lag and sleep disorders.
Scientists have solved the structure of a human protein called AGT, which repairs damaged DNA inside human cells. The protein can inadvertently protect cancer cells from chemotherapy agents, rendering them ineffective.
Scientists Gary Bokoch and colleagues discovered the mechanism by which Rac is released from RhoGDI, revealing a critical role for p21-activated kinase (Pak) in regulating cell motility. This breakthrough offers insights into tumor growth, immune responses, and neurological diseases.
Researchers found that suppressing CBP function in adult rodents impaired long-term memory, but administering a histone deacetylase inhibitor corrected this defect. This suggests remodeling of chromatin is essential for learning and memory, and may offer new treatment options for cognitive disorders.
Scripps researchers successfully engineered E. coli to produce myoglobin proteins with 22 amino acids, including unnatural O-methyl-L-tyrosine and L-homoglutamine. This breakthrough demonstrates the genetic code can be expanded beyond 20 amino acids, opening doors for novel protein designs.
A new hypothesis suggests that autoimmunity is triggered by insufficient immune stimulation, leading to a decrease in T cells and an overactive expansion of the remaining population. This condition, known as lymphopenia, can cause diseases like Type 1 diabetes and rheumatoid arthritis.
Beutler's work uses forward genetics to study human genes used by the innate immune system. He identified a protein called Trif, which helps the body respond to viruses and bacteria.
Researchers have discovered the role of cadherin 23 protein in the mechanotransduction process that converts sound waves into electrical signals. The study provides insights into Usher syndrome and age-related hearing loss, suggesting a potential therapeutic target for treating deafness.
Researchers at Scripps Research Institute have discovered a way to block fluid leakage that causes long-term tissue injury after a heart attack. A single dose of a compound can drastically reduce tissue injury and increase long-term survival following a heart attack.
A new hypothesis suggests that Alzheimer's disease arises from inflammation, leading to the creation of abnormal metabolites that modify amyloid beta proteins. These misfolded proteins accumulate into fibrils and plaques, causing neuronal loss and contributing to the disease.
Research reveals a strong relationship between drugs of abuse, stress, and the amygdala, suggesting CRF receptor blockers may be a new therapeutic for alcoholics. The study highlights the complex neurobiology of addiction, with compounds blocking CRF receptors potentially providing relief from relapse.
Researchers at Scripps Research Institute have identified a compound called cardiogenol C that can selectively differentiate embryonic stem cells into heart muscle cells. This breakthrough could potentially lead to the development of new treatments for repairing damaged heart tissue.
Researchers at Scripps Research Institute solved the structure of a regulatory protein that controls gene expression by recognizing specific RNA sequences. The discovery provides valuable insights into post-transcriptional gene regulation and its potential to target diseases such as inflammation.
A genetic mutation in the CCR5 gene does not offer protection against HIV infection, according to new research by Scripps scientist Donald Mosier. The study tested the hypothesis that the mutation, which appeared in Europe during the Middle Ages, protected against both HIV and plague.
Researchers at Scripps Research have created a single, clonable strand of DNA that folds into an octahedron with potential applications in biomedical science, electronics, and computing. The structure can be amplified and replicated using standard molecular biology tools.
The researchers solved the structure of the hemagglutinin protein, a crucial component in understanding the 1918 flu outbreak. The study reveals that the virus likely originated from birds and its unique surface proteins made it particularly deadly to young adults.
Researchers at Scripps Research Institute find normal cellular prion protein essential for prion diseases like BSE, and inducing neurotoxicity without scrapie prions triggers catastrophic outcomes. This discovery highlights the complexity of prion pathogenesis and challenges existing therapeutic approaches.
The research team, led by Chi-Huey Wong, discovered a way to make homogeneous pools of glycosylated proteins in E. coli, overcoming previous bottlenecks and challenges. This new method has the potential to be more efficient, scalable, and cost-effective than existing technologies.
Scientists at Scripps Research Institute discover a compound, reversine, that can convert muscle cells into precursor cells, which can be converted to other cell types. This breakthrough has the potential to revolutionize stem cell research and make it more practical for medical applications.
Scientists have discovered a key role for lipid metabolism in the regulation of the immune system. The study reveals that natural killer T cells can recognize lipids on the surface of bacteria, triggering an immune response. By understanding this process, researchers hope to develop new treatments for autoimmune diseases and cancer.
Researchers found a polymorphism in the SCL40A1 gene that increases iron storage protein levels, leading to primary iron overload. The mutation is more common in African populations and may explain the high incidence of the disease among African-Americans.
Researchers detected 'atheronals', toxic compounds triggered by ozone in atherosclerotic plaques, suggesting a potential diagnostic marker for late-stage arterial inflammation. Ozone's role in human biology and its implications on diseases like lupus, multiple sclerosis, and rheumatoid arthritis are also explored.
Researchers have found that injecting adult bone marrow-derived stem cells into the back of mouse eyes curtails retinal degeneration and restores normal retinal tissue. The treated mice had improved vision and responded to light, offering a potential new approach for treating retinitis pigmentosa.
A study at TSRI identifies 62 new proteins in the inner nuclear membrane linked to 14 rare diseases, including muscular dystrophy and Charcot-Marie-Tooth disease. This discovery has significant implications for understanding the underlying causes of these devastating conditions and developing new therapeutic strategies.
Researchers at TSRI introduce a revolutionary method to add unnatural amino acids to the genetic code of Saccharomyces cerevisiae yeast. This allows for unprecedented control over protein structure and function, enabling new insights into biological processes and potential therapeutic applications.
Researchers at Scripps Research Institute identify a single protein called Trif that associates with different receptors to detect pathogens, triggering immune reactions. The protein could be a potential target for intervening in diseases like sepsis.